- Home
- TXMD vs FVR Comparison
TXMD vs FVR Comparison
Compare TXMD & FVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- FVR
- Stock Information
- Founded
- TXMD 2008
- FVR 2016
- Country
- TXMD United States
- FVR United States
- Employees
- TXMD N/A
- FVR N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- FVR
- Sector
- TXMD Health Care
- FVR
- Exchange
- TXMD Nasdaq
- FVR NYSE
- Market Cap
- TXMD 12.8M
- FVR 227.7M
- IPO Year
- TXMD N/A
- FVR 2024
- Fundamental
- Price
- TXMD $1.18
- FVR $12.48
- Analyst Decision
- TXMD
- FVR Hold
- Analyst Count
- TXMD 0
- FVR 5
- Target Price
- TXMD N/A
- FVR $16.80
- AVG Volume (30 Days)
- TXMD 44.7K
- FVR 356.6K
- Earning Date
- TXMD 08-11-2025
- FVR 08-15-2025
- Dividend Yield
- TXMD N/A
- FVR 6.86%
- EPS Growth
- TXMD N/A
- FVR N/A
- EPS
- TXMD N/A
- FVR N/A
- Revenue
- TXMD $1,841,000.00
- FVR $60,901,000.00
- Revenue This Year
- TXMD $427.09
- FVR $18.42
- Revenue Next Year
- TXMD N/A
- FVR $6.26
- P/E Ratio
- TXMD N/A
- FVR N/A
- Revenue Growth
- TXMD 53.55
- FVR 15.85
- 52 Week Low
- TXMD $0.70
- FVR $10.61
- 52 Week High
- TXMD $2.44
- FVR $19.76
- Technical
- Relative Strength Index (RSI)
- TXMD 48.98
- FVR N/A
- Support Level
- TXMD $0.98
- FVR N/A
- Resistance Level
- TXMD $1.21
- FVR N/A
- Average True Range (ATR)
- TXMD 0.09
- FVR 0.00
- MACD
- TXMD 0.01
- FVR 0.00
- Stochastic Oscillator
- TXMD 80.00
- FVR 0.00
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About FVR FRONTVIEW REIT INC
FrontView REIT Inc is an internally managed net-lease REIT that is experienced in acquiring, owning, and managing out parcel properties that are net-leased to a diversified group of tenants. The tenants of the company include service-oriented businesses, such as restaurants, cellular stores, financial institutions, automotive stores and dealers, medical and dental providers, pharmacies, convenience and gas stores, car washes, home improvement stores, grocery stores, professional services as well as general retail tenants.